Month: January 2020

VANCOUVER, British Columbia, Jan. 22, 2020 (GLOBE NEWSWIRE) — Nanotech Security Corp. (TSXV: NTS) (OTCQX: NTSFF) (“Nanotech” or the “Company”), a leader in the development of secure and memorable nano-optic security features used in the government and banknote and brand protection markets, announces it will attend the Optical Document Security Conference on January 29-31, 2020 in San Francisco. This is a key event for Nanotech as it is one of the largest conferences focusing on technical and scientific developments in optical security for documents and products of value.Nanotech’s Chief Technology Officer Clint Landrock will be showcasing Nanotech’s latest KolourDepth™ security feature. Exclusive to the government and banknote industry, KolourDepth delivers an always-on feature encompassing...

WAYNE, Pa., Jan. 22, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration for the WattsonTM Temporary Pacing Guidewire – the first commercially available bipolar temporary pacing guidewire designed specifically for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV).This innovative device offers clinicians a 0.035” pigtailed guidewire that supports valve delivery and allows simultaneous intraventricular bipolar pacing during TAVR or BAV procedures. WattsonTM Temporary Pacing Guidewire is designed to simplify and shorten TAVR procedures by eliminating the need for routine use of central venous access...

Company AnnouncementNet trade sales of DARZALEX in 2019 totaled USD 2,998 millionGenmab to receive milestone payment of USD 150 million in DARZALEX collaborationMilestone triggered by sales of DARZALEX reaching USD 3 billion in the calendar year of 2019 as calculated on the basis of the license agreement termsCopenhagen, Denmark; January 22, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX® (daratumumab) as reported by Johnson & Johnson were USD 2,998 million in 2019. Net trade sales were USD 1,567 million in the U.S. and net trade sales in the rest of the world were USD 1,430 million. Genmab receives royalties on the worldwide net sales of DARZALEX as calculated on the basis of the license agreement terms under the exclusive worldwide license to Janssen Biotech, Inc. (Janssen)...

BRØNDBYERNES I.F. FODBOLD A/SCVR-nr. 83 93 34 10Brøndby, den 22. januar 2020SELSKABSMEDDELELSE NR. 02/2020Brøndbyernes I.F. Fodbold A/S – Tegningstilsagn fra Jan Bech Andersen og TBC Holding ApS samt støtteerklæring fra Jan Bech AndersenI forbindelse med forberedelse af emissionen, som meddelt ved selskabsmeddelelse nr. 14/2019 af 11. oktober 2019, har Jan Bech Andersen og TBC Holding ApS, afgivet bindende tegningstilsagn om at ville tegne aktier ved at konvertere den fulde gæld, som selskabet har til Jan Bech Andersen og TBC Holding ApS på tidspunktet for emissionens gennemførelse. Tilsagnene er betinget af, at Brøndby IF gennemfører emissionen således, at handel med tegningsretter er begyndt inden den 1. april 2020.Jan Bech Andersen har tillige bekræftet,...

CHICAGO, Jan. 22, 2020 (GLOBE NEWSWIRE) — TransUnion Healthcare (NYSE: TRU) today announced that its Insurance Discovery solution was recognized as a revenue cycle unicorn by KLAS®, a global research and insights firm addressing the healthcare IT (HIT) industry. TransUnion Healthcare was included as one of the companies featured in the KLAS Revenue Cycle Unicorns 2019 report.The designation comes at a time when hospitals are struggling to collect on care provided. Earlier this month, the American Hospital Association issued a report that found hospitals spent $41.3 billion providing uncompensated care in 2018, an increase of 7.5% from $38.4 billion in 2017.To meet the needs of its more than 1800 hospital and health system clients, TransUnion Healthcare’s Revenue Protection® solutions, including Insurance Discovery,...

ORION CORPORATION  STOCK EXCHANGE RELEASE 22 JANUARY 2020 at 12.45 EET        Recommendation by the Nomination Committee concerning the Board of Directors to be elected by the 2020 AGM of Orion CorporationThe Nomination Committee of Orion Corporation has on 22 January 2020 given to the company’s Board of Directors its recommendation for the proposal to the Annual General Meeting of 2020 concerning the composition of the Board of Directors to be elected by the meeting. The Committee recommends that the following proposal be presented to the AGM of 2020:The number of Board members would be seven.Of the present members of the Board, Pia Kalsta, Ari Lehtoranta, Timo Maasilta, Hilpi Rautelin, Eija Ronkainen and Mikael Silvennoinen would be re-elected for the next term of office and Kari Jussi...

ORION OYJ                          PÖRSSITIEDOTE                  22.1.2020        KLO 12.45         Orionin varsinaisessa yhtiökokouksessa 2020 valittavaa hallitusta koskeva nimitysvaliokunnan suositusOrion Oyj:n nimitysvaliokunta on 22.1.2020 antanut yhtiön hallitukselle suosituksen vuoden 2020 varsinaiselle yhtiökokoukselle tehtävästä ehdotuksesta kokouksessa valittavan hallituksen kokoonpanoksi. Valiokunta suosittaa seuraavan ehdotuksen tekemistä Orion Oyj:n varsinaiselle yhtiökokoukselle 2020:Hallituksen jäsenten...

Los Angeles & Desert Hot Springs, California, Jan. 22, 2020 (GLOBE NEWSWIRE) — Grapefruit Boulevard Investments, Inc., (“GBI”) a licensed and fully compliant California based cannabis distribution and manufacturing company and a wholly owned subsidiary of Imaging3, Inc., a Delaware corporation (OTCQB: IGNG) (collectively “Grapefruit” or the “Company”) is announcing today that it filed Amendment No. 1 to its Registration Statement on Form S-1 originally filed on July 28, 2019. The Registration Statement covers shares to be issued to its institutional investor, Auctus Fund, LLC. (“Auctus”) of Boston, MA in connection with conversions of Convertible Notes (the “Notes”) issued to Auctus at 95% of Market and upon exercise of callable cash exercise only Warrants issued by...

22 January 2020IQE plc(“IQE” or the “Company”)Holding(s) in Company